Study design:
Retrospective cohort study.
Objective:
To investigate the prognosis of symptomatic pseudarthrosis observed at 1 year after lateral lumbar interbody fusion (LLIF) surgery and to analyze the risk factors for persistent pseudarthrosis for 2 years postoperatively.
Summary of background data:
Few papers have evaluated the prognosis of symptomatic pseudarthrosis following LLIF surgery.
Methods:
One hundred fifty-two patients with a minimum follow-up of 2 years were screened. Fusion status was assessed at 1 year postoperatively, and unfused segments were re-evaluated at 2 years postoperatively. Dynamic X-rays and CT images were acquired to evaluate the fusion status. Demographic data were evaluated to identify the risk factors associated with persistent pseudarthrosis. Clinical outcomes, including the visual analog scale (VAS) for back/leg pain and the Oswestry disability index (ODI), were evaluated preoperatively and at 1 and 2 years postoperatively.
Results:
Symptomatic pseudarthrosis was detected in 42 patients at 1 year postoperatively. Among them, 23 patients (54.8%) exhibited solid bony fusion 2 years postoperatively without further intervention. Fourteen patients (33.3%) showed asymptomatic pseudarthrosis, and the remaining 5 patients (11.9%) showed symptomatic pseudarthrosis. Multivariable analysis showed that diabetes (adjusted OR: 2.817, p = 0.007), smoking (adjusted OR: 6.497, p = 0.008), and fusion at more than 3 levels (adjusted OR: 2.525, p = 0.031) were risk factors for persistent pseudarthrosis. Improvements in the VAS scores for back pain and ODI scores were significantly lower in the persistent pseudarthrosis group than in the final solid fusion group at 2 years postoperatively.
Conclusion:
It is not necessary to intervene for all patients in whom symptomatic pseudarthrosis is detected at 1 year postoperatively because only 11.9% of them will show persistent symptomatic pseudarthrosis. However, early revision surgery should be considered when severe symptomatic pseudarthrosis associated with diabetes, smoking, and fusion at more than 3 levels is present.Level of Evidence: 4.